USD 3.64
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 175.08 Million | -182.47 Million | -155.32 Million | 71.34 Million | 57.48 Million | 20.71 Million |
Net Income | -79.78 Million | -316.78 Million | -195.24 Million | -101.97 Million | 16.66 Million | 14.71 Million |
Depreciation & Amortization | 135.46 Million | 115.12 Million | 73.72 Million | 47.33 Million | 44.47 Million | 14.49 Million |
Deferred income taxes | -289.24 Million | -14.54 Million | -3.92 Million | 85.88 Million | 14.67 Million | 4.98 Million |
Stock-based compensation | 36.43 Million | 25.13 Million | 30.36 Million | 23.88 Million | 9.32 Million | 5.22 Million |
Change in working capital | 18.12 Million | 12.55 Million | -63.95 Million | -28.73 Million | -30.47 Million | -19.97 Million |
Other non-cash items | 354.09 Million | -3.95 Million | 3.71 Million | 44.95 Million | 2.82 Million | 1.26 Million |
Investing Cash Flow | -51.2 Million | -110.29 Million | -98.82 Million | -73.75 Million | -35.09 Million | 16.97 Million |
Investments in PPE | -51.2 Million | -54.28 Million | -83.63 Million | -73.75 Million | -35.09 Million | -6.99 Million |
Acquisitions | - | -56 Million | -15.19 Million | - | - | 23.96 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -1000.00 | -32.31 Million | -48.3 Million | 1000.00 | -28.72 Million | -5.33 Million |
Financing Cash Flow | -25.73 Million | -120.99 Million | -45.63 Million | 1.09 Billion | -6.61 Million | -8.24 Million |
Debt repayment | -4 Million | -1.91 Million | -34.68 Million | -2.5 Million | -6.5 Million | -5.5 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -3000.00 | -87.67 Million | -87.99 Million | - | - | - |
Common Stock Issuance | 3000.00 | - | 94.48 Million | 1.2 Billion | 3.5 Million | 1.67 Million |
Other Financing Activities | -21.73 Million | -31.4 Million | -17.43 Million | -108.21 Million | -3.62 Million | -4.42 Million |
Accounts receivables | 1.35 Million | -19.13 Million | -90.65 Million | -230.52 Million | -65.01 Million | -35.27 Million |
Accounts payables | 16.76 Million | 31.68 Million | 26.7 Million | 201.79 Million | 34.53 Million | 15.3 Million |
Inventory | - | - | - | - | - | - |
Other working capital | 16.76 Million | - | - | - | - | - |
Cash at beginning of period | 419.3 Million | 803.85 Million | 1.1 Billion | 75.51 Million | 59.42 Million | 29.48 Million |
Cash at end of period | 522.69 Million | 419.3 Million | 803.85 Million | 1.1 Billion | 75.51 Million | 59.42 Million |
Capital Expenditure | -51.2 Million | -54.28 Million | -83.63 Million | -73.75 Million | -35.09 Million | -6.99 Million |
Effect of forex changes on cash | 5.23 Million | 29.21 Million | 2.97 Million | -71.61 Million | 324 Thousand | 491 Thousand |
Net cash flow / Change in cash | 103.38 Million | -384.54 Million | -296.8 Million | 1.02 Billion | 16.09 Million | 29.93 Million |
Free Cash Flow | 123.88 Million | -236.75 Million | -238.95 Million | -2.4 Million | 22.38 Million | 13.72 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 7.03 Million | 45.4 Million | -79.78 Million | -58.55 Million | -25.43 Million | -24.99 Million |
Depreciation & Amortization | 19.54 Million | 19.8 Million | 135.46 Million | 99.99 Million | 27.12 Million | 42.84 Million |
Deferred income taxes | - | - | -289.24 Million | -223.14 Million | -4.42 Million | 2.98 Million |
Stock-based compensation | 4.57 Million | 9.43 Million | 36.43 Million | 10.81 Million | 7.6 Million | 8.52 Million |
Change in working capital | 48.79 Million | 19.98 Million | 18.12 Million | -12.32 Million | -2.58 Million | 29.38 Million |
Other non-cash items | -7.03 Million | 45.87 Million | 354.09 Million | 233.01 Million | -4.01 Million | -3.21 Million |
Investing Cash Flow | -7.2 Million | -8.74 Million | -51.2 Million | -12.48 Million | -3.38 Million | -9.16 Million |
Investments in PPE | -7.45 Million | -8.74 Million | -51.2 Million | -12.48 Million | -3.38 Million | -9.16 Million |
Acquisitions | 255 Thousand | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -6.24 Million | -7.5 Million | -1000.00 | -10.96 Million | -3.03 Million | -8.1 Million |
Financing Cash Flow | -114.83 Million | -3.41 Million | -25.73 Million | -6.49 Million | -6.36 Million | -7.13 Million |
Debt repayment | -273 Thousand | -367 Thousand | -4 Million | -1.72 Million | -631 Thousand | -1.14 Million |
Dividends payments | -111.74 Million | - | - | - | - | - |
Common Stock Repurchased | - | - | -3000.00 | -3000.00 | - | - |
Common Stock Issuance | 609 Thousand | - | 3000.00 | 3000.00 | - | - |
Other Financing Activities | -822 Thousand | -879 Thousand | -21.73 Million | -4.76 Million | -5.73 Million | -5.99 Million |
Accounts receivables | 69.11 Million | -20.74 Million | 1.35 Million | -67.26 Million | 7.15 Million | 36.71 Million |
Accounts payables | -20.32 Million | 40.72 Million | 16.76 Million | 54.93 Million | -9.74 Million | -7.32 Million |
Inventory | - | - | - | - | - | - |
Other working capital | -20.32 Million | - | - | - | - | - |
Cash at beginning of period | 628.07 Million | 522.69 Million | 419.3 Million | 494.34 Million | 507.7 Million | 465.88 Million |
Cash at end of period | 586.5 Million | 628.07 Million | 522.69 Million | 522.69 Million | 494.34 Million | 507.7 Million |
Capital Expenditure | -7.45 Million | -8.74 Million | -51.2 Million | -12.48 Million | -3.38 Million | -9.16 Million |
Effect of forex changes on cash | 2.44 Million | 6.1 Million | 5.23 Million | -2.48 Million | -1.88 Million | 2.57 Million |
Net cash flow / Change in cash | -41.56 Million | 105.38 Million | 103.38 Million | 28.34 Million | -13.35 Million | 41.82 Million |
Free Cash Flow | 70.57 Million | 102.69 Million | 123.88 Million | 37.31 Million | -5.1 Million | 46.38 Million |
LAND
SKAN
002045
EOSEW
GIGANTE
OHCS